CFR
- Title 1 - General Provisions
- Title 2 - Grants and Agreements
- Title 3 - The President
- Title 4 - Accounts
- Title 5 - Administrative Personnel
- Title 6 - Domestic Security
- Title 7 - Agriculture
- Title 8 - Aliens and Nationality
- Title 9 - Animals and Animal Products
- Title 10 - Energy
- Title 11 - Federal Elections
- Title 12 - Banks and Banking
- Title 13 - Business Credit and Assistance
- Title 14 - Aeronautics and Space
- Title 15 - Commerce and Foreign Trade
- Title 16 - Commercial Practices
- Title 17 - Commodity and Securities Exchanges
- Title 18 - Conservation of Power and Water Resources
- Title 19 - Customs Duties
- Title 20 - Employees' Benefits
- Title 21 - Food and Drugs
- Title 22 - Foreign Relations
- Title 23 - Highways
- Title 24 - Housing and Urban Development
- Title 25 - Indians
- Title 26 - Internal Revenue
- Title 27 - Alcohol, Tobacco Products and Firearms
- Title 28 - Judicial Administration
- Title 29 - Labor
- Title 30 - Mineral Resources
- Title 31 - Money and Finance: Treasury
- Title 32 - National Defense
- Title 33 - Navigation and Navigable Waters
- Title 34 - Education
- Title 35 - Panama Canal
- Title 36 - Parks, Forests, and Public Property
- Title 37 - Patents, Trademarks, and Copyrights
- Title 38 - Pensions, Bonuses, and Veterans' Relief
- Title 39 - Postal Service
- Title 40 - Protection of Environment
- Title 41 - Public Contracts and Property Management
- Title 42 - Public Health
- Title 43 - Public Lands: Interior
- Title 44 - Emergency Management and Assistance
- Title 45 - Public Welfare
- Title 46 - Shipping
- Title 47 - Telecommunication
- Title 48 - Federal Acquisition Regulations System
- Title 49 - Transportation
- Title 50 - Wildlife and Fisheries
SUBPART G—Specific Labeling Requirements for Specific Drug Products (§201.300 to §201.326)
- 201.300—Notice to manufacturers, packers, and distributors of glandular preparations.
- 201.301—Notice to manufacturers, packers, and distributors of estrogenic hormone preparations.
- 201.302—Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil.
- 201.303—Labeling of drug preparations containing significant proportions of wintergreen oil.
- 201.304—Tannic acid and barium enema preparations.
- 201.305—Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings.
- 201.306—Potassium salt preparations intended for oral ingestion by man.
- 201.307—Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale.
- 201.308—Ipecac syrup; warnings and directions for use for over-the-counter sale.
- 201.309—Acetophenetidin (phenacetin)-containing preparations; necessary warning statement.
- 201.310—Phenindione; labeling of drug preparations intended for use by man.
- 201.312—Magnesium sulfate heptahydrate; label declaration on drug products.
- 201.313—Estradiol labeling.
- 201.314—Labeling of drug preparations containing salicylates.
- 201.315—Over-the-counter drugs for minor sore throats; suggested warning.
- 201.316—Drugs with thyroid hormone activity for human use; required warning.
- 201.317—Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning.
- 201.319—Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (including, but not limited to agar, alginic acid, calcium polycarbophil, carboxymethylcellulose sodium, carrageenan, ch
- 201.320—Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting substances.
- 201.323—Aluminum in large and small volume parenterals used in total parenteral nutrition.
- 201.325—Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required warnings and labeling information.
- 201.326—Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling.
Tips